Desisobutyryl ciclesonide
CAS: 161115-59-9
Ref. 3D-FD21205
1mg | A consultar | ||
2mg | A consultar | ||
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar |
Información del producto
- (11b,16a)-16,17-[[(R)-Cyclohexylmethylene]bis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dioneCIC-APCiclesonide active principle
- CIC-AP
- Pregna-1,4-diene-3,20-dione, 16,17-[(cyclohexylmethylene)bis(oxy)]-11,21-dihydroxy-, [11β,16α(R)]-
- Ciclesonide active principle
- Pregna-1,4-diene-3,20-dione, 16,17-[[(R)-cyclohexylmethylene]bis(oxy)]-11,21-dihydroxy-, (11β,16α)-
- (11β,16α)-16,17-[[(R)-Cyclohexylmethylene]bis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
Desisobutyryl ciclesonide is a prodrug of ciclesonide, which is a potent and specific beta-adrenergic agonist. It has been shown to have a pharmacokinetic profile that is similar to the parent drug, with an elimination half-life of approximately six hours. Desisobutyryl ciclesonide is not metabolized by cytochrome P450 enzymes and has low oral bioavailability. The drug does not produce any significant adverse effects in animal studies when administered orally or intravenously.
Propiedades químicas
Consulta técnica sobre: 3D-FD21205 Desisobutyryl ciclesonide
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.